epocrates logo
epocrates logo
epocrates logo
  • 0

Herbs & Supplements

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

close

 

Select a medication above to begin.

xi yang shen

ginseng, American (Panax quinquefolius)

Sections:

  • Entire Monograph
  • Reported Uses
  • Reported Doses
  • Cautions
  • Drug Interactions
  • Adverse Reactions
  • Synonyms
  • Other Info
  • Add to Interaction Check

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies with variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Special Note

[formulation clarification]
Info: extracts generally standardized to 0.052-11.65% ginsenoside content

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

ADHD, peds patients

[Insufficient Evidence]
Dose: 200 mg PO bid; Info: for patients 3-17 yo; used with ginkgo

cancer-related fatigue

[Insufficient Evidence]
Dose: 1 g PO bid

cognitive function

[Insufficient Evidence]
Dose: 100-400 mg PO x1; Alt: 100-200 mg PO qd

diabetes mellitus, type 2

[Insufficient Evidence]
Dose: 3 g PO x1 up to 2h before a meal; Alt: 1.5 g PO qd; Info: used with or without Asian ginseng

heart failure

[Insufficient Evidence]
Dose: 0.6 g PO tid; Info: used with conventional tx

HTN

[Insufficient Evidence]
Dose: 0.5-1 g PO tid; Info: used with or without Asian ginseng

menopausal symptoms

[Insufficient Evidence]
Dose: 50 mg PO bid

schizophrenia

[Insufficient Evidence]
Dose: 100 mg PO bid

URI

[Possibly Effective]
Dose: 200-400 mg PO bid

Copyright © 2026. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.

Select a medication above to begin.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information